David Arkowitz, Chief Financial Officer at Flexion Therapeutics Inc (FLXN), bought 4,000 shares at $16.56 ($66K) on 2018-11-09, disclosed to the SEC on 2018-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| MCRB | SELL | 2023-10-31 | $5K | — | Filing → |
| FLXN | SELL | 2021-05-12 | $16K | — | Filing → |
| FLXN | SELL | 2021-01-07 | $135K | — | Filing → |